| Literature DB >> 35956179 |
Małgorzata Foryś-Basiejko1,2,3, Katarzyna Kotulska2, Agnieszka Maryniak1, Agata Siłuszyk3, Monika Szkop2, Julita Borkowska2, Monika Sugalska3, Jagoda Głowacka-Walas4,5, Sergiusz Jóźwiak3.
Abstract
This paper aimed to assess language development in infants and toddlers with tuberous sclerosis complex (TSC) and epilepsy, which increase the risk of autism spectrum disorder. We assessed language development in 61 patients with TSC at 8-36 months using a standardized Speech Development and Communication Inventory tool. The results showed differences in outcomes due to the duration of the seizures and the number of drugs (pFDR = 0.007 **-pFDR = 0.037 *). Children with TSC with longer epilepsy duration and receiving more antiepileptic drugs have a greater risk of language development delay.Entities:
Keywords: epilepsy; gesture production; language development; tuberous sclerosis complex; vocabulary
Year: 2022 PMID: 35956179 PMCID: PMC9369686 DOI: 10.3390/jcm11154564
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Descriptive statistics for age of the study participants and number of study participants with regard to sex, the reason for treatment introduction, genetic alteration, age of the first occurrence of seizures and risk of delayed language development.
| 8–18 Months | 19–36 | All | ||
|---|---|---|---|---|
|
| ||||
| Mean | 12.7 | 26.1 | 18.7 | |
| SD | 2.4 | 4.8 | 7.6 | |
| median | 12.5 | 25 | 16 | |
| quartile 1 | 12 | 23 | 12 | |
| quartile 3 | 14 | 28.5 | 24 | |
|
| ||||
| Female | 16 (47%) | 12 (44%) | 28 (46%) | |
| Male | 18 (53%) | 15 (56%) | 33 (54%) | |
|
| ||||
| No treatment needed | 3 (9%) | 5 (19%) | 8 (13%) | |
| abEEG | 15 (44%) | 10 (37%) | 25 (42%) | |
| Clinical seizures | 16 (47%) | 11 (41%) | 27 (44%) | |
| No information | NA | 1 (3%) | 1 (2%) | |
|
| ||||
| | 3 (9%) | 2 (7%) | 5 (8%) | |
| | 14 (41%) | 4 (15%) | 18 (30%) | |
| No identify | 2 (6%) | 0 | 2 (3%) | |
| No information | 15 (44%) | 21 (78%) | 36 (59%) | |
|
| ||||
| No seizures | 11 (32%) | 9 (33%) | 20 (33%) | |
| First seizure: 1–12 months | 21 (62%) | 11 (41%) | 32 (52%) | |
| First seizure: 13–24 months | 1 (3%) | 6 (22%) | 7 (12%) | |
| No information about first seizure | 1 (3%) | 1 (4%) | 2 (3%) | |
|
| ||||
| ≤10 percentile (HR-DLD) | 23 (77%) | 10 (37%) | 33 (54%) | |
| >10 percentile | 11 (32%) | 17 (53%) | 28 (46%) | |
|
| ||||
| ≤10 percentile (HR-DLD) | 18 (53%) | NA | NA | |
| >10 percentile | 16 (47%) | NA | NA | |
|
| ||||
| ≤10 percentile (HR-DLD) | 9 (26%) | NA | NA | |
| >10 percentile | 25 (74%) | NA | NA | |
SCDI-WG—Speech Development and Communication Inventory-Word and Gestures, SCDI-WS—Speech Development and Communication Inventory-Word and Sentences, SD—standard deviation, abEEG—epileptic alterations on EEG, HR-DLD—High risk of delayed language development.
The comparison of results of the SDCI questionnaire according to age of seizure onset, the reason for antiepileptic treatment introduction, duration of the seizure presence, number of currently taken antiepileptic drugs, and observed response to present treatment (i.e., decrease in seizure, seizure remission, or no response).
| 8–36 Months | 19–36 Months | 8–18 Months | ||||
|---|---|---|---|---|---|---|
| Expressive Vocabulary | Expressive Vocabulary | Expressive Vocabulary | Receptive Vocabulary | Gestures | ||
|
|
| 39 | 17 | 22 | 22 | 22 |
|
| 0.064 | 0.094 | 0.167 | 0.15 | 0.614 | |
|
| 0.209 | 0.209 | 0.209 | 0.209 | 0.614 | |
|
| 122.5 | 20 | 37.5 | 37.5 | 51.5 | |
|
|
| 52 | 21 | 31 | 31 | 31 |
|
| 0.42 | 0.796 | 0.126 | 0.174 | 0.083 | |
|
| 0.557 | 0.892 | 0.290 | 0.290 | 0.290 | |
|
| 393.5 | 63.5 | 159 | 154 | 161 | |
|
|
| 41 | 18 | 23 | 23 | 23 |
|
| 0.531 | 0.879 | 1 | 0.888 | 0.438 | |
|
| 1 | 1 | 1 | 1 | 1 | |
|
| 172 | 38 | 56.5 | 53.5 | 45 | |
|
|
| 36 | 17 | 19 | 19 | 19 |
|
| 0.001 ** | 0.149 | 0.145 | 0.109 | 0.193 | |
|
| 0.005 * | 0.186 | 0.186 | 0.186 | 0.193 | |
|
| 13.218 | 3.81 | 3.86 | 4.43 | 3.29 | |
|
|
| 60 | 27 | 34 | 34 | 34 |
|
| 0.002 ** | 0.042 * | 0.054 | 0.004 ** | 0.009 ** | |
|
| 0.010 * | 0.053 | 0.054 | 0.010 * | 0.013 * | |
|
| 12.19 | 6.36 | 5.82 | 10.88 | 9.54 | |
|
|
| 36 | 16 | 20 | 20 | 20 |
|
| 0.047 * | 0.192 | 0.803 | 0.828 | 0.836 | |
|
| 0.480 | 0.230 | 0.828 | 0.828 | 0.828 | |
| 6.14 | 3.30 | 45.5 | 39 | 45 | ||
n—number of study participants in the analysis; p—statistical significance; p—statistical significance after continuity correction; U—Wilcoxon test statistic; H—Kruskal–Wallis statistic. * p < 0.05, ** p < 0.01.
Results of post-hoc analyses for the tested variables in expressive vocabulary, receptive vocabulary, and gestures.
| Duration of Seizures | Response to Treatment | ||||||
|---|---|---|---|---|---|---|---|
| Expressive Vocabulary (8–36) | Expressive Vocabulary (8–36) | ||||||
| <1 month | 1–6 months | >6 months | Seizure remission | Decrease in number of seizures | No changes | ||
| ( | ( | ( | ( | ( | ( | ||
| <1 month | x | Remission | x | ||||
| 1–6 months | x | Decrease | x | ||||
| >6 months | x | No changes | x | ||||
|
| |||||||
| Expressive Vocabulary (8–36) | Expressive vocabulary (19–36) | ||||||
| No drugs | 1 drug | min. 2 drugs | No drugs | 1 drug | min. 2 drugs | ||
| ( | ( | ( | ( | ( | ( | ||
| No drugs | x | x | |||||
| 1 drug | x | x | |||||
| min. 2 drugs | x | x | |||||
| Receptive Vocabulary (8–18) | Gestures (8–18) | ||||||
| No drugs | 1 drug | min. 2 drugs | No drugs | 1 drug | min. 2 drugs | ||
| ( | ( | ( | ( | ( | ( | ||
| No drugs | x | x | |||||
| 1 drug | x | x | |||||
| min. 2 drugs | x | x | |||||
n—number of study participants in the analysis; Me—Median; p—statistical significance with Benjamini-Hochberg Procedure. * p < 0.05, ** p < 0.01.
Figure 1Quartile distribution of statistically significant results: duration of seizures, response to treatment, and the number of drugs. The Y axis indicates the SCDI percentile score. On the X axis, there are names of groups of individual variables. * p < 0.05, ** p < 0.01 range.